Integer CEO Khales Payman bought 3,127 shares of the company's stock on Oct. 30, 2025. Mr. Payman purchased his company's stock on the day shares hit a 52-week low of $62.

Shares of medical technology company Integer Holdings (NYSE:ITGR) fell 31.4% in the afternoon session after the company ...

Integer Holdings’ third quarter results were overshadowed by management’s acknowledgment of unexpected headwinds tied to ...

Integer Holdings Corporation revises 2026 outlook, signaling flat growth. Click for potential ITGR investment opportunities ...

ITGR stock fell 48.7% from a high of $99.66 on July 29, 2021, to $51.11 on October 10, 2022, compared to a peak-to-trough ...

What Happened: Khales's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, involves purchasing 3,127 shares of Integer Holdings. The total ...

For the current year, Integer trimmed its outlook slightly. It now expects sales to rise 7% to 8%, versus its prior view of 8% to 9% growth, while adjusted earnings is now expected to be $6.29 to ...

The average one-year price target for Integer Holdings (NYSE:ITGR) has been revised to $95.30 / share. This is a decrease of ...

Integer Holdings announced today that Payman Khales has taken over the corner office at the medtech contract manufacturing ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Continued strong sales and profit growth in 3Q25 ~~ Updating 2025 sales and profit outlook; providing preliminary outlooks for 2026 and 2027 ...

Guidance for 2025 was revised downward for sales (reduced by $16 million at midpoint), adjusted operating income (down $3 million at midpoint), and adjusted EPS (down $0.02). In Q2, management had ...